The History of Peptide Therapy: From Insulin to Modern Therapeutics

Written by Adam Maggio | Medically reviewed by Dr. Sarah Chen, PharmD, BCPS

Peptide therapy's history spans over a century, beginning with insulin's discovery in 1921, which proved the therapeutic potential of amino acid chains. Key advancements like Frederick Sanger's sequencing of insulin and Robert Bruce Merrifield's solid-phase peptide synthesis revolutionized research. The 21st century marks a 'Golden Age' with GLP-1 agonists and regenerative peptides, demonstrating their power in targeted healing and disease management.

The History of Peptide Therapy: From Early Discoveries to Modern Medicine

Peptide therapy isn't a new phenomenon; its roots stretch back over a century, marking a fascinating journey from rudimentary extracts to highly sophisticated, targeted therapeutics. The evolution of our understanding and application of peptides reflects some of the most significant breakthroughs in biochemistry and medicine. You'll find that the story of peptides is one of continuous discovery, driven by a desire to harness the body's own signaling systems for healing.

The Dawn of Peptide Discovery: Insulin's Legacy

The true beginning of peptide therapy can be traced to the early 20th century, specifically to the groundbreaking work on insulin. In 1921, Frederick Banting and Charles Best, working under John Macleod, successfully isolated insulin from the pancreas and demonstrated its ability to lower blood glucose in diabetic dogs. This monumental discovery, which earned Banting and Macleod a Nobel Prize in 1923, marked the first successful therapeutic use of a peptide [1]. Insulin, a 51-amino acid peptide hormone, proved that naturally occurring biological molecules could be extracted and used to treat life-threatening conditions. Its clinical application began in 1922, revolutionizing the treatment of diabetes and saving countless lives [2].

This early success with insulin laid the foundation, proving the concept that short chains of amino acids could exert profound physiological effects. Unlike the complex synthesis of many small-molecule drugs, insulin's initial therapeutic use involved direct extraction, a testament to its inherent biological activity.

Unraveling the Structure: The Mid-20th Century

The mid-20th century saw significant advancements in understanding peptide structure. In 1953, Frederick Sanger elucidated the complete amino acid sequence of insulin, a feat that earned him another Nobel Prize in 1958 [3]. This was a pivotal moment, demonstrating that the precise order of amino acids dictated a peptide's function. This knowledge paved the way for the chemical synthesis of peptides.

In 1963, Robert Bruce Merrifield developed solid-phase peptide synthesis (SPPS), a revolutionary technique that dramatically simplified and accelerated the creation of peptides in the laboratory. Merrifield's innovation, recognized with a Nobel Prize in 1984, transformed peptide research, making it possible to synthesize custom peptides with specific sequences for study and therapeutic development [4]. This was a game-changer, allowing scientists to move beyond extraction to bespoke design.

Expansion of Therapeutic Applications: Late 20th Century

With improved synthesis methods, the therapeutic potential of peptides began to expand beyond insulin. Early examples included vasopressin and oxytocin, both small peptide hormones, which found clinical use in managing blood pressure and labor induction, respectively. The 1980s and 1990s saw the emergence of a new wave of peptide drugs, including:

These developments highlighted the versatility of peptides in targeting a wide array of physiological pathways. Unlike the broad-acting effects of some traditional drugs, these peptides demonstrated highly specific interactions with their receptors, often leading to fewer off-target effects.

The Golden Age of Peptides: 21st Century and Beyond

The 21st century has been dubbed the "Golden Age of Peptide Therapeutics." Advances in biotechnology, computational design, and delivery systems have propelled peptides to the forefront of drug discovery. Key trends and breakthroughs include:

Today, peptides constitute a significant portion of newly approved drugs, with over 80 peptide drugs currently on the market and hundreds more in clinical development [6]. This rapid growth is a testament to their efficacy, specificity, and generally favorable safety profiles.

Practical Takeaway

The history of peptide therapy is a compelling narrative of scientific ingenuity leading to profound medical advancements. From insulin's life-saving introduction to the targeted therapeutics of today, peptides have consistently demonstrated their power to modulate human physiology. If you're considering peptide therapy, understanding this rich history underscores the scientific rigor and evolving sophistication behind these treatments. You'll want to partner with a practitioner who appreciates this lineage and stays current with the latest research, ensuring you benefit from the most advanced and well-understood peptide protocols available.